ICD-10 Code B40.2 | Pulmonary blastomycosis, unspecified Symptoms, Diagnosis, Billing

Pulmonary blastomycosis, unspecified is a fungal infection caused by the organism Blastomyces dermatitidis, primarily affecting the lungs. It is clinically significant due to its potential to cause severe respiratory illness and systemic complications. Accurate coding with ICD-10 Code B40.2 ensures proper diagnosis, documentation, medical billing, and aids in public health reporting, facilitating effective management of this infectious disease.

What is ICD-10 Code B40.2 for Pulmonary blastomycosis, unspecified?

ICD-10 Code B40.2 represents pulmonary blastomycosis that is unspecified, indicating a diagnosis of this fungal infection without specific details on its severity or complications. This code is used when the clinical presentation aligns with pulmonary blastomycosis but lacks further specification, ensuring appropriate documentation and billing in clinical settings.

ICD-10 Code B40.2 – Clinical Definition and Explanation of Pulmonary blastomycosis, unspecified

Pulmonary blastomycosis, unspecified is caused by inhalation of spores from the fungus Blastomyces dermatitidis, leading to respiratory symptoms and potential systemic involvement. Early recognition and treatment are crucial to prevent severe complications.

Key Clinical Features:

• Cough, which may be productive or dry.
• Fever and chills, indicating systemic infection.
• Chest pain or discomfort, often exacerbated by breathing.
• Weight loss and fatigue, common in chronic cases.

ICD-10 Code B40.2 for Pulmonary blastomycosis, unspecified – SOAP Notes & Clinical Use

ICD-10 Code B40.2 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code B40.2 for Pulmonary blastomycosis, unspecified Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B40.2 connects subjective patient-reported symptoms with objective clinical findings, facilitating a formal diagnosis. This code supports continuity of care, aids in billing processes, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B40.2 – Pulmonary blastomycosis, unspecified

Pulmonary blastomycosis, unspecified may require hospitalization for severe cases. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

• First-line: Itraconazole, typically for 6-12 months.
• Alternative: Amphotericin B for severe cases or those not responding to itraconazole.

Supportive Care:

• Oxygen therapy for hypoxemia.
• Fluid management to prevent dehydration.
• Pain management for chest discomfort.

Infection Control:

• Standard precautions to prevent transmission.
• Isolation if the patient is immunocompromised.

How to Document Symptoms of Pulmonary blastomycosis, unspecified (ICD-10 B40.2) in SOAP Notes

Subjective:

• Patient reports persistent cough for 2 weeks.
• Experiences fever and night sweats.
• Complains of chest pain, especially during deep breaths.
• Notable weight loss over the past month.

Objective:

• Wheezing noted on auscultation.
• Respiratory rate: 22 breaths per minute.
• Oxygen saturation: 92% on room air.
• Chest X-ray shows infiltrates consistent with fungal infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Pulmonary blastomycosis, unspecified (ICD-10 Code B40.2)

Assessment:

• Diagnosis: Pulmonary blastomycosis, unspecified, moderate severity.
• ICD-10 Code: B40.2.
• Triggers: Recent travel to endemic areas.
• Contributing factors: Immunocompromised status.

Plan:

• Initiate itraconazole therapy.
• Educate patient on medication adherence and potential side effects.
• Monitor oxygen saturation and respiratory status.
• Schedule follow-up in 4 weeks to assess treatment response.

Treatment & Plan Section for ICD-10 Code B40.2 – Pulmonary blastomycosis, unspecified

• First-line pharmacologic treatment: Itraconazole.
• Non-pharmacologic strategies: Smoking cessation and avoidance of respiratory irritants.
• Monitoring practices: Regular follow-up appointments and chest imaging.
• Patient education on recognizing worsening symptoms.

Using ICD-10 Code B40.2 for Pulmonary blastomycosis, unspecified in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
• Use B40.2 in settings such as emergency departments and infectious disease clinics.
• Include detailed patient history and treatment plans to support billing.
• Align treatment plans with clinical guidelines to justify coding.

Related ICD-10 Codes Often Used with Pulmonary blastomycosis, unspecified

• B40.0 – Pulmonary blastomycosis, acute
• B40.1 – Pulmonary blastomycosis, chronic
• B40.9 – Blastomycosis, unspecified

ICD-10 Code B40.2 in Medical Billing and Insurance for Pulmonary blastomycosis, unspecified

ICD-10 Code B40.2 is essential for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and patient history to support the use of B40.2.
• Use this code in conjunction with detailed treatment plans for accurate billing.
• Ensure compliance with payer requirements for documentation.
• Review coding guidelines regularly to maintain accuracy.

Common CPT Pairings: